Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) said its open offer of new stock brought in £1.2 million, bringing the total proceeds from this and the company’s share subscription placing to £11.9 million. The cash injection will be used to continue the exciting work on its SCIB 1/SCIB + development programmes. Last month, researchers shared highly encouraging results from a group of hard-to-treat melanoma patients. The new investment will also be deployed to keep up the clinical momentum with its Modi-1 programme.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com